Information  X 
Enter a valid email address

Tiziana Life SciencesPLC Ord3P (TILS)

Date Time Source Announcement
30 Sep 2020 7:00 am
RNS
Half-year Report
25 Sep 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Interview - Bloomberg International
21 Sep 2020 2:11 pm
RNS
Publication of Research Note
  7:00 am
RNS
Issue of Equity and Total Voting Rights
17 Sep 2020 7:00 am
RNS
Clinical Study with Nasally Administered Foralumab
16 Sep 2020 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Demerger of StemPrintER and Distribution in Specie
07 Sep 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
02 Sep 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
28 Aug 2020 12:04 pm
RNS
Holding(s) in Company
  10:30 am
RNS
ADS Registration Statement Filing Clarification
27 Aug 2020 4:00 pm
RNS
Exercise of Warrants and Issue of Equity
  7:00 am
RNS
Tiziana CEO Interview
26 Aug 2020 7:00 am
RNS
Grant of Options - Director Dealings
24 Aug 2020 7:00 am
RNS
Patent Granted for Anti-IL-6/IL-6
21 Aug 2020 7:00 am
RNS
Patent Granted for Milciclib
20 Aug 2020 7:00 am
RNS
Update - Scientific Advisory Board
18 Aug 2020 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Patent Granted for Foralumab
11 Aug 2020 8:49 am
RNS
BTIG's Virtual Biotechnology Conference
10 Aug 2020 7:00 am
RNS
Holding(s) in Company
05 Aug 2020 4:00 pm
RNS
Closing of $57.25 Million Offering
04 Aug 2020 7:00 am
RNS
Expedited Clinical Development Plan
03 Aug 2020 7:00 am
RNS
Issue of Equity
31 Jul 2020 5:00 pm
RNS
Total Voting Rights
  4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Submission of a Patent Application for Foralumab
30 Jul 2020 4:30 pm
RNS
Proposed Admission to the Official List
  11:53 am
RNS
Update on Timings and Corporate Actions
  7:00 am
RNS
Investor Webinar to Provide Corporate Updates
29 Jul 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
24 Jul 2020 7:00 am
RNS
Exercise of Warrants and Issue of Equity
20 Jul 2020 2:51 pm
RNS
Director Appointment
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
16 Jul 2020 11:39 am
RNS
Result of AGM
  7:00 am
RNS
Submission of Patent Application
15 Jul 2020 4:29 pm
RNS
Change to ADS Ratio - Updated
  1:00 pm
RNS
Change to ADS Ratio
14 Jul 2020 9:06 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
13 Jul 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
10 Jul 2020 6:01 pm
RNS
Interview to Air on Bloomberg International
01 Jul 2020 7:00 am
RNS
Total Voting Rights and StemPrintER Update
29 Jun 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  8:12 am
GNW
Tiziana Life Sciences Announces Agreement with STC Biologics for GMP Manufacturing of an anti-Interleukin-6-Receptor Monoclonal Antibody for Clinical Studies in Patients with COVID-19
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t